Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.290
-0.040 (-3.01%)
At close: May 8, 2026, 4:00 PM EDT
1.340
+0.050 (3.88%)
Pre-market: May 11, 2026, 7:18 AM EDT
Bionano Genomics Revenue
In the year 2025, Bionano Genomics had annual revenue of $28.51M, down -7.37%. Bionano Genomics had revenue of $7.95M in the quarter ending December 31, 2025, a decrease of -2.60%.
Revenue (ttm)
$28.51M
Revenue Growth
-7.37%
P/S Ratio
0.50
Revenue / Employee
$293,897
Employees
97
Market Cap
14.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 28.51M | -2.27M | -7.37% |
| Dec 31, 2024 | 30.78M | -5.34M | -14.79% |
| Dec 31, 2023 | 36.12M | 8.31M | 29.90% |
| Dec 31, 2022 | 27.80M | 9.82M | 54.62% |
| Dec 31, 2021 | 17.98M | 9.48M | 111.47% |
| Dec 31, 2020 | 8.50M | -1.63M | -16.06% |
| Dec 31, 2019 | 10.13M | -1.87M | -15.59% |
| Dec 31, 2018 | 12.00M | 2.50M | 26.26% |
| Dec 31, 2017 | 9.51M | 2.71M | 39.93% |
| Dec 31, 2016 | 6.79M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harvard Bioscience | 86.55M |
| Retractable Technologies | 38.27M |
| Precision Optics Corporation | 24.42M |
| Jin Medical International | 20.69M |
| Nephros | 18.79M |
| NEXGEL | 11.42M |
| Milestone Scientific | 8.97M |
| Lucyd | 2.66M |
BNGO News
- 2 days ago - Bionano Genomics files $400M mixed securities shelf - TheFly
- 4 days ago - Bionano Genomics CEO Erik Holmlin to step down, Al Luderer to succeed - TheFly
- 4 days ago - Bionano Announces Leadership Transition - GlobeNewsWire
- 5 days ago - Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 - GlobeNewsWire
- 11 days ago - Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 - GlobeNewsWire
- 4 weeks ago - Bionano Genomics price target lowered to $6 from $7 at H.C. Wainwright - TheFly
- 5 weeks ago - Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma - GlobeNewsWire
- 6 weeks ago - Bionano Genomics Earnings Call Transcript: Q4 2025 - Transcripts